Ftse Mib
38.225,82
-0,95%
DAX
22.620,95
-1,65%
S&P 500
5.614,56
-2,70%
NASDAQ
17.468,32
-4,00%
Bitcoin
79.634,95
1,48%
Pepperstone
Advertisement
Registration Strip Icon for monitor Monitora più quotazioni in tempo reale dalle principali borse, come Borsa Italiana, NASDAQ, NYSE, AMEX, Bovespa e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Codexis Inc (CDXS) Codexis Inc (CDXS) Notizie

Codexis Inc

CDXS
2,65
-0,17 (-6,03%)
11 Mar 2025 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
10/3/202522:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202522:05GLOBECodexis Announces New Employment Inducement Grants
06/3/202522:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/2/202522:20EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
27/2/202522:18EDGAR2Form 8-K - Current report
27/2/202522:05GLOBECodexis Reports Fourth Quarter and Fiscal Year 2024..
18/2/202522:05GLOBECodexis to Participate in TD Cowen 45th Annual Health Care..
14/2/202523:15GLOBECodexis Announces New Employment Inducement Grants
13/2/202522:05GLOBECodexis to Report Fourth Quarter and Fiscal Year 2024..
13/2/202501:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/2/202502:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/2/202502:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/2/202502:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/2/202502:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/2/202522:05GLOBECodexis Appoints Arthur Levin, PhD, to Strategic Advisory..
01/2/202501:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/1/202500:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/1/202523:04EDGAR2Form 8-K - Current report
16/1/202522:05GLOBECodexis Appoints Christos Richards to Board of Directors
10/1/202522:05GLOBECodexis Announces New Employment Inducement Grants
02/1/202522:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/12/202422:05GLOBECodexis Announces New Employment Inducement Grants
19/11/202422:05GLOBECodexis to Participate in Piper Sandler 36th Annual..
14/11/202422:53EDGAR2Form SCHEDULE 13G/A - Statement of Beneficial Ownership by..
14/11/202422:05GLOBECodexis Unveils Pioneering Enzymatic Synthesis Data to..
12/11/202422:25EDGAR2Form 3 - Initial statement of beneficial ownership of..
12/11/202422:05GLOBECodexis Announces Appointment of Raymond De Vré, PhD, to..
12/11/202422:01EDGAR2Form 8-K - Current report
11/11/202422:05GLOBECodexis TIDES Europe Presentations to Feature Next Step in..
08/11/202422:05GLOBECodexis Announces New Employment Inducement Grants
04/11/202422:05GLOBECodexis to Participate in Upcoming Healthcare Conferences
31/10/202421:18EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
31/10/202421:16EDGAR2Form 8-K - Current report
31/10/202421:05GLOBECodexis Reports Third Quarter 2024 Financial Results
28/10/202421:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/10/202422:05GLOBECodexis Announces Three siRNA Manufacturing Data..
22/10/202422:05GLOBEArtiva Biotherapeutics Appoints Alison Moore, Ph.D., to Its..
22/10/202422:00EDGAR2Form 8-K - Current report
14/10/202413:05GLOBECodexis Announces New Employment Inducement Grants
11/10/202400:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/10/202400:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/10/202400:19EDGAR2Form 3 - Initial statement of beneficial ownership of..
10/10/202422:05GLOBECodexis to Report Third Quarter 2024 Financial Results on..
02/10/202422:30EDGAR2Form 8-K - Current report
02/10/202422:05GLOBECodexis Increases Cash Reserves and Enhances Management Team..
01/10/202413:05GLOBECodexis Licenses Genomics Life Science Enzyme Portfolio to..
26/9/202421:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/9/202415:27EDGAR2Form SC 13G - Statement of Beneficial Ownership by Certain..
23/9/202423:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/9/202400:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
Apertura: 2,78 Min: 2,555 Max: 2,78
Chiusura: 2,82

La tua Cronologia

NASDAQ
CDXS
Codexis
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network

Rimuovi gli annunci

Iscriviti per un'esperienza senza pubblicità

Nessuna pubblicità

Prova adesso

Conserva gli annunci